Nurix Therapeutics Cash Flow Statement (2019-2026) | NRIX

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Aug2019 Nov2019 Feb2020 May2020 Aug2020 Nov2020 Feb2021 May2021 Aug2021 Nov2021 Feb2022 May2022 Aug2022 Nov2022 Feb2023 May2023 Aug2023 Nov2023 Feb2024 May2024 Aug2024 Nov2024 Feb2025 May2025 Aug2025 Nov2025 Feb2026
Operating Activities
Net Income (Quarter) -2.43M-13.28M-12.39M7.58M-18.52M-19.95M-24.27M-26.34M-28.84M-37.70M-42.53M-45.40M-45.71M-46.72M-40.73M-24.28M-36.98M-41.96M-41.52M-44.55M-48.96M-58.55M-56.35M-43.46M-86.42M-78.22M-87.17M
Share-based Compensation (Quarter) 0.14M0.17M0.18M0.21M0.55M2.54M2.70M1.93M2.21M4.84M6.07M6.78M4.23M8.30M8.48M8.72M8.45M8.02M7.82M8.85M8.75M8.51M8.72M10.38M9.77M9.09M9.40M
Gains from Sales and Divestitures (Quarter) 0.01M0.03M
Gains from Investment Securities (Quarter) 1.91M3.46M4.39M5.10M5.14M0.21M-12.80M6.44M0.45M-0.20M0.02M0.02M0.03M0.00M0.00M1.30M-1.58M4.39M5.79M32.49M2.72M
Non-cash Items (Quarter) 0.76M2.99M141.25M2.85M48.90M54.90M65.69M75.20M68.20M3.20M
Cash from Operations (Quarter) -12.75M40.97M-14.43M-6.14M-20.48M8.05M-31.54M-29.97M-30.91M-42.63M-32.91M-46.31M-37.95M-48.45M-18.47M-41.13M26.69M-41.95M-39.70M-42.18M-48.75M-61.09M-63.16M-57.38M-67.83M-71.91M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) -0.01M-0.04M-0.08M-0.14M0.74M-1.31M-0.53M4.39M1.26M-2.25M-0.08M6.54M0.82M2.05M0.59M1.97M1.84M2.25M3.71M3.49M3.56M1.08M3.82M1.66M1.58M
Depreciation & Amortization (CF) (Quarter) 0.60M0.59M0.49M0.50M0.60M0.68M0.60M0.60M0.70M0.77M0.99M1.30M1.50M1.57M1.75M1.90M1.95M1.93M2.04M2.33M2.39M2.55M2.35M2.24M2.03M2.12M2.20M
Change in Working Capital
Change in Receivables (Quarter) 2.00M-2.00M
Change in Account Payables (Quarter) 0.04M0.30M1.45M-1.14M0.63M0.90M1.22M-1.39M0.86M-0.10M1.85M-0.76M-0.90M0.40M-2.24M-1.20M4.65M-0.93M-2.54M1.09M7.58M-3.21M-2.68M2.23M3.02M-0.46M
Change in Accured Expenses (Quarter) 1.61M1.43M-3.32M2.46M1.70M2.17M-2.86M3.53M3.38M-3.32M6.14M1.36M3.30M-6.91M2.26M4.70M3.08M3.59M-6.84M6.04M9.02M6.94M-7.01M6.34M11.04M4.12M
Change in Taxes (Quarter) -15.73M-0.01M0.14M-0.84M-2.94M
Other Working Capital Changes (Quarter) -0.27M54.63M-52.58M45.31M-43.43M-0.74M-0.82M-0.88M16.68M1.51M0.00M-23.86M23.44M-9.18M-5.68M12.30M22.07M-1.17M-6.51M2.91M-23.78M-9.83M12.79M1.98M1.28M-1.25M
Investing Activities
Capital Expenditures (Quarter) 0.95M0.36M1.61M1.67M0.91M0.84M-0.24M0.23M1.67M2.21M0.49M6.99M2.56M1.43M1.92M-2.30M7.35M0.85M3.97M2.35M2.10M3.48M2.67M-4.04M-0.94M1.70M
Change in Acquisitions & Divestments (Quarter) 5.02M10.50M46.20M73.48M64.21M55.02M58.75M62.81M72.77M84.48M40.99M105.62M99.82M76.61M93.20M95.98M110.83M159.50M139.20M142.34M156.19M179.81M133.15M
Cash from Investing Activities (Quarter) -4.37M-19.42M-2.34M-108.08M-124.56M-2.39M-57.11M-12.23M-36.52M40.03M-4.76M-63.08M55.01M16.07M43.83M22.77M-14.37M35.51M-131.07M-21.34M-140.82M25.53M71.50M50.48M0.35M-123.83M
Financing Activities
Cash from Financing Activities (Quarter) 0.08M0.05M119.68M220.42M-1.13M1.36M150.47M1.55M0.50M1.49M0.43M115.41M-0.14M1.48M0.03M1.70M0.01M1.62M237.75M45.77M200.52M1.47M0.01M1.16M236.01M19.98M
Additional items
Change in Cash (Quarter) -17.03M21.59M102.92M106.20M-146.17M7.03M61.83M-40.65M-66.93M-1.11M-37.25M6.02M16.92M-30.90M25.39M-16.65M12.32M-4.81M66.98M-17.75M10.95M-34.08M8.34M-5.75M168.52M-175.76M
Free Cash Flow (Quarter) -13.70M40.61M-16.04M-7.81M-21.39M7.21M-31.30M-30.20M-32.58M-44.84M-33.40M-53.29M-40.52M-49.89M-20.39M-38.83M19.34M-42.81M-43.67M-44.52M-50.86M-64.57M-65.84M-53.34M-66.89M-73.61M
Net Cash Flow (Quarter) -17.03M21.59M102.92M106.20M-146.17M7.03M61.83M-40.65M-66.93M-1.11M-37.25M6.02M16.92M-30.90M25.39M-16.65M12.32M-4.81M66.98M-17.75M10.95M-34.08M8.34M-5.75M168.52M-175.76M